Pipeline partnerships Elorac has a robust pipeline of novel dermatology products protected by patents or proprietary technologies, signaling strong licensing, co development, or investment opportunities to monetize development and speed to market with reduced upfront risk.

Lean team partnerships With a lean, agile team, Elorac could scale through strategic partnerships spanning manufacturing, distribution, and commercialization, especially for specialty dermatology channels such as clinics, dermatology distributors, and specialty pharmacies.

US market expansion Located in the Chicago area, Elorac is well positioned to expand US market access for dermatology products, making it a fit for regional distribution deals, co promotion agreements, and physician focused marketing collaborations.

IP moat Proprietary technologies and patent protection create defensible product value, enhancing attractiveness for exclusive licenses, co branded initiatives, or platform collaborations around dermatology indications.

Growth capital fit A growing development slate and current revenue profile could align with strategic investments, partnerships, or grant funded collaborations to advance pipeline programs and early commercialization.